arrow
J

Jürgen Rech

university of erlangen nuremberg
H指数:54
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of apremilast on entheseal bone damage in psoriasis patients at risk of developing psoriatic arthritis - data from the prospective, interventional EPOS study

阿普米拉斯特对处于银屑病关节炎发展风险中的银屑病患者附着点骨骼损伤的影响——来自前瞻性、干预性EPOS研究的数据

2026-08-080
OAAI
Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints

皮肤衍生的骨髓前体和关节驻留的成纤维细胞将银屑病疾病从皮肤传播到关节

2026-01-020
OAAI
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease

BCMA T细胞结合疗法在难治性自身免疫性疾病患者中的应用

2025-10-164
PRE
Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomised phase IIa clinical trial (RCT)

安全性、耐受性及罗万帕他滨(又称BC007)对后COVID综合征患者疲劳和生命质量的影响:一项前瞻性、探索性、安慰剂对照、双盲、随机IIa期临床试验(RCT)

2025-07-220
PRE
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study

疾病相关脑激活预测类风湿关节炎中TNF抑制的临床反应(PreCePra):一项随机、多中心、双盲、安慰剂对照的III期研究

2025-06-230
OAAI
First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study

成人发病斯蒂尔病中,一线生物制剂与常规合成改善病情抗风湿药治疗的比较:一项多中心、回顾性、倾向性加权队列研究

2025-03-280
OAAI
Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's Disease

成人斯蒂尔病患者的遗传景观和新型炎症生物标志物的表征

2024-12-160
OAAI
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial
LANCET
IF88.5
2024-03-0130
PRE
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo- controlled, phase 2 trial
2023-06-0114
PRE
Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO Trial
2023-05-281
OAAI